ACROBiosystems’ new strategic focus – streamlining the transition from preclinical development to commercialization
(Adnkronos) – BASEL, Switzerland, March 30, 2023 /PRNewswire/ — ACROBiosystems has begun to narrow its focus into helping accelerate the process between preclinical, clinical and commercialization. With over 10 years development, ACROBiosystems continues
